Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland.
Ignacio García DovalMiguel Angel Descalzo-GallegoKayleigh J MasonArnon D CohenA D OrmerodF J Gómez-GarcíaSimone CazzanigaI FeldhamerH AliE Herrera-AcostaC E M GriffithsRobert S SternLuigi Naldinull nullPublished in: The British journal of dermatology (2018)
Cumulative length of exposure to biological therapies in patients with psoriasis in real-world clinical practice does not appear to be linked to a higher risk of cancer after several years of use.